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Abstract
Background: Clostridium difficile and Clostridium perfringens are commonly associated with colitis in equids, but
healthy carriers exist. Scarce information is available on the prevalence of Clostridium spp. in gastrointestinal
compartments other than faeces in healthy horses, and it is unknown whether faecal samples are representative of
proximal compartments. The objectives were to investigate the prevalence of C. difficile and C. perfringens in
different intestinal compartments of healthy adult horses and to determine whether faecal samples are
representative of colonization in proximal sites and overall carrier status.
Results: Toxigenic C. difficile was isolated from 14/135 (10.3%) samples from 8/15 (53.3%) horses. Between zero and
three sites were positive per horse, and multiple sites were positive in four horses. Isolates were recovered from
duodenum, jejunum, ileum, right dorsal colon, small colon and rectum. When multiple compartments were positive
in a single horse, two different C. difficile ribotypes were always present. Clostridium perfringens Type A (CPE, β2
toxin gene negative) was recovered from the left ventral colon of one horse (0.74%, 1/135 samples). Agreement
between faeces and overall C. difficile carrier status was good.
Conclusions: Clostridium difficile can be found in different compartments of the gastrointestinal tract of healthy
horses, and multiple strains can be present in an individual horse. The prevalence of C. perfringens in healthy adult
hoses was low, consistent with previous reports. Faecal samples were representative for presence of C. difficile in
proximal compartments in 5/8 horses (63%) but were not representative for the specific strain.
Keywords: Clostridium difficile, Clostridium perfringens, Equine gastrointestinal tract, Equine intestinal microflora,
Clostridium difficile ribotyping
Background
Over the past decade Clostridium difficile has emerged as
an important enteric pathogen in human [1] and veterin-
ary medicine [2]. Clostridium difficile is an important
cause of acute enterocolitis in horses [3-5] with clinical
signs ranging from mild self-limiting disease to fulminant
necro-haemorrhagic enterocolitis [6]. While clearly a
cause of disease in horses, toxigenic strains of C. difficile
can also be isolated from faeces of healthy horses, with
reported isolation rates of 0% to 8% [5,7-9]. While there
are numerous point prevalence studies, there has been
limited study of colonization of C. difficile in different ana-
tomic locations throughout the intestinal tract. Clostrid-
ium difficile infection (CDI) is typically associated with
colonic disease in horses and humans. More recently CDI
has also been connected with small intestinal enteritis in
humans [10] and with proximal duodenitis jejunitis in
horses [11]. This suggests that C. difficile is also able to
colonize the small intestine.
Clostridium perfringens has been associated with entero-
colitis in animals, including horses and humans [12,13]. In
an earlier study C. perfringens type A has been reported to
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be a normal part of the gastrointestinal flora of healthy
horses [14]. Interestingly recent studies have reported low
prevalence rates of 0-8% in faeces of healthy adult horses
[5,13,15-17]. This organism is mostly associated with co-
lonic disease but has been also identified in the small in-
testine of horses with gastrointestinal disease [15], in
horses with grass sickness and in healthy horses [13].
Nevertheless, clear information about the distribution of
C. perfringens in the proximal intestinal tract and informa-
tion on shedding of this organism over time in healthy
horses is lacking.
Faecal samples are commonly being used to test for
presence C. difficile and C. perfringens; however, disease
does not occur in the distal parts of the gastrointestinal
system where the faecal microbiota is established, it
occurs in proximal components of the intestinal tract.
The physiology and local environments of different in-
testinal tract locations are quite variable and it is logical
that the intestinal microbiota is similarly variable. This is
important to study because faecal samples are most
often used for diagnosis of intestinal tract disease or for
epidemiological studies, yet the degree to which they re-
flect the status of proximal intestinal tract locations is
currently unknown.
Therefore, the objectives of this study were to investi-
gate the presence of C. difficile and C. perfringens in
various intestinal compartments of healthy adult horses
and to molecularly characterize isolates.
Methods
Intestinal contents were collected from 15 euthanized
horses greater than one year (Table 1) and free of appar-
ent clinical signs of gastrointestinal disease. The horses
were euthanized for reasons unrelated to this study. The
legal and ethical requirements of the University of
Guelph have been met with regards to the humane treat-
ment of animals described in the study.
Within four hours after euthanasia samples were col-
lected from the stomach, duodenum, jejunum, ileum,
body of the caecum, right dorsal colon, left ventral
colon, small colon and rectum. Samples were collected
asepetically via enterotomy and intestinal content was
collected using sterile forceps and stored at −80°C until
processing.
Clostridium difficile culture
Two grams of intestinal content or faeces were inocu-
lated into C. difficile moxalactam and norfloxacin broth
(CDMN)a and anaerobically incubated at 37°C for five
to seven days. An aliquot of the broth was alcohol
shocked with an equal volume of anhydrous ethanol for
one hour. This mixture was centrifuged for ten minutes
at 3800 g. The supernatant was discarded and the pellet
was streaked onto a CDMN agar plate and
anaerobically incubated for 48 hours at 37°C. Suspicious
colonies were subcultured onto blood agar, anaerobic-
ally incubated for 24 hours at 37°C, and confirmed as
C. difficile by colony morphology, characteristic odour
and production of L-proline aminopeptidase (Pro Disc
Remel)b.
DNA extraction
DNA was extracted from a pure culture on blood agar
with a Chelex resin-based DNA extraction commercial
kit (Insta Gene)c, using the manufacturer’s instructions.
The resulting DNA was used as template for subsequent
PCR tests.
Ribotyping of C. difficile
A previously described ribotyping method was used to
analyse all positive isolates [18]. When the ribotype
was a recognized international ribotype previously
identified by the PHLS Anaerobic Reference Unit
(Cardiff, UK), the appropriate numerical designation
(i.e. 078) was used. Otherwise, in-house nomenclature
was assigned.
Table 1 Epidemiologic data of horses included in the
study
Horse # Farm Age in
years
Gender Breed Reason for
euthanasia
1 # A 3 MC Thoroughbred Cervical vertebral
malformation
2 B 14 F Welsh Pony Pulmonary calcification
3 C 4 F Bashkir Curly EDM
3 # C 3 F Bashkir Curly EDM
5 # D 3 M Standardbred Cervical vertebral
malformation
6 C 3 F Bashkir Curly EDM
7 # C 2 M Bashkir Curly EDM
8 C 4 F Bashkir Curly EDM
9 E 3 F Standardbred Cervical vertebral
malformation
10 # C 4 MC Bashkir Curly EDM
11 # F 8 MC Irish Sport
Horse
Fracture L5
12 # G 3 F Standardbred Cervical vertebral
malformation
13 H 4 MC Standardbred Cervical vertebral
malformation
14 I 3 F Standardbred Cervical vertebral
malformation
15 # J 6 MC Hannoverian Cervical vertebral
malformation
# horses from which C. difficile was isolated from at least 1 compartment
M=male non castrated, MC=male castrated, F = female, EDM= Equine
Degenerative Myeloencephalopathy.
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Toxin gene profiling of C. difficile
PCR detection of genes encoding toxins A (tcdA) and B
(tcdB) was performed as previously described [19]. The
presence of binary toxin (CDT) was tested by amplifica-
tion of a fragment of the gene (cdtB) [20].
Clostridium perfringens culture
Two grams of intestinal content or faeces were inocu-
lated into 8 ml brain heart infusion broth (BHI)d and an-
aerobically incubated for two days at 37°C. After
incubation an aliquot of the broth was alcohol shocked
with an equal volume of anhydrous ethanol for one hour
and then centrifuged at 3800 g for ten minutes. The
supernatant was discarded, and the resulting pellet was
inoculated onto blood agar and anaerobically incubated
at 37°C for 48 hours. Clostridium perfringens colonies
were identified by colony morphology and double-zone
hemolysis. Suspicious colonies were subcultured on
blood agar and anaerobically incubated for 48 hours at
37°C. Christie-Atkins-Munch –Peterson (CAMP) testing
was performed on colonies accompanied by a positive
control (NTC 3110, NTC 8840).
Clostridium perfringens multiplex PCR
Typing of C. perfringens was based on genes encoding
all four major toxins as well as enterotoxin and β2 as
described previously [21].
Statistical analysis
Kappa values were calculated to compare agreement be-
tween positive rectum/faecal samples and overall carrier
status of C. difficile. Agreement was interpreted as fol-
lows: poor agreement = kappa less than 0.20, fair agree-
ment = kappa 0.20 to 0.40, moderate agreement = kappa
0.40 to 0.60, good agreement = kappa 0.60 to 0.80, very
good agreement = kappa 0.80 to 1.00 [22]. The remaining
data were analysed in a descriptive manner.
Results
Epidemiologic data of horses and farms
Fifteen horses of more than one year were included in
the study (Table 1). These horses originated from ten
farms, six horses from a single premise and the
remaining nine from different farms. Information on
diet, housing and administration of drugs including anti-
microbials was not available.
Clostridium difficile prevalence
Clostridium difficile was isolated from 14/135 (10.3%)
samples from 8/15 (53.3%) horses on 6/10 (60%) farms.
Between zero and three/nine (33%) sites were positive
per horse, and multiple sites were positive in four (27%)
horses (Table 2). Isolates were recovered from the duo-
denum (n = 1/15, 6.7%), jejunum (n = 1/15, 6.7%), ileum
(n = 1/15, 6.7%), right dorsal colon (n = 4/15, 27%), small
colon (n = 2/15, 13.3%), and rectum/faeces (n = 5/15,
33%). In three horses (38%) C. difficile was isolated from
a proximal site but the rectal samples were negative,
while in 3 (38%) other horses the rectum and a proximal
site were positive and in 2 (25%) horses the rectum was
the only positive site. The relative sensitivity of faecal
sample culture to detect overall C: difficile presence in a
horse was 63% (CI 95%:0.29 and 0.89). Agreement be-
tween rectal and proximal samples (all proximal sites
combined) was good (kappa = 0.61, standard error 0.19).
Clostridium difficile toxin detection and ribotyping results
All isolates possessed genes encoding for toxins A and B
(Table 2). Five isolates were ribotype 078 and also pos-
sessed the gene encoding for part of the binary toxin
(cdtB). Four isolates were ribotype 001 and were cdtB
negative. The remaining five isolates corresponded to
three ribotype profiles not previously identified in this
laboratory. These five isolates were tcdA and tcdB posi-
tive, but were cdtB negative. Interestingly, more than
one ribotype was found in all horses from which mul-
tiple compartments were positive.
Prevalence and characterization of C. perfringens
Clostridium perfringens was only isolated from the left
ventral colon of one horse. The detection limit of the
method used was low at 9 cfu/g (data not shown). The
single isolate contained only the alpha toxin gene, classi-
fying it as C. perfringens type A.
Table 2 Ribotypes and toxin gene profiles of Clostridium
difficile isolated from gastrointestinal compartments of
healthy horses
Horse Farm Compartment Toxin A Toxin B CDT Ribotype1
1 A Rectum + + + 078
4 C Right Dorsal Colon + + - 001
Rectum + + + 078
5 D Right Dorsal Colon + + - 001
Rectum + + + 078
7 C Duodenum + + + 078
Right Dorsal Colon + + - 001
Rectum + + + 078
10 C Small colon + + - 001
11 F Jejunum + + - AS2
Ileum + + - AS1
Right Dorsal Colon + + - AS1
12 G Rectum + + - AS1
15 J Small colon + + - AS3
1 PHLS Anaerobic Reference Unit (Cardiff, UK) when appropriate, otherwise,
internal nomenclature was used.
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Discussion
This study showed that C. difficile can be isolated from a
variety of gastrointestinal compartments of healthy
horses and that several distinct ribotypes may be isolated
from the same horse. Explanations for the different ribo-
types in the same horse include simultaneous transient
passage of multiple strains through the gastrointestinal
system or colonization of different compartments by di-
verse strains. Regardless, these data indicate that the typ-
ical practice of selecting one colony for typing, an
almost universal procedure in studies that have reported
C. difficile types in horses [23,24], might underestimate
the true ribotype diversity and distribution. Human
studies have reported co-existence of different ribotypes
in faecal specimens from healthy humans and those
affected with CDI [25,26]; however, the presence of mul-
tiple strains is rarely reported. In a study of healthy
humans, Kato and co-workers (2001) reported that only
1/94 (1.1%) faecal samples positive for C. difficile con-
tained more than one ribotype per sample. Similar data
have not been available for horses, but this study sug-
gests that methods able to detect different ribotypes in a
single sample might be required to get a true under-
standing of the ribotype distribution in equine samples.
Regardless, the potential presence of multiple C. difficile
strains in the same animal must be considered when
designing and interpreting studies.
Clostridium difficile was found in various locations
throughout the intestinal tract, which is not surprising
given its association with both small and large intestinal
disease. As with any study of the intestinal microbiota, it
is impossible to definitively state that C. difficile was
truly colonizing these locations as opposed to passing
through transiently following ingestion. This study can-
not differentiate between these two, but demonstrates
that this organism is adapted to survive and perhaps
proliferate in various intestinal locations. Further investi-
gations into the dynamics of C. difficile and ways to dif-
ferentiate transient passage from colonization are
required.
Inconsistent detection of C. difficile in different intes-
tinal compartments of the same horse could be due to
non-homogenous distribution of C. difficile in truly colo-
nized animals, intestinal site predilections for C. difficile
(or specific strains), or presence of C. difficile below de-
tection thresholds at some sites.
Overall the prevalence of C. difficile in the gastrointes-
tinal tract of horses found in this study (53%) was higher
compared to other studies (typically 0-10%), including
those performed in the same geographical region [5,7-9];
however, prevalence data should be interpreted with
caution, as the study was not designed to determine
population prevalence. Also, the presence of multiple
animals per farm may have introduced a clustering
effect. Six horses in this study originated from one farm,
and C. difficile was isolated from 3/6 (50%) of them, po-
tentially slightly over estimating overall prevalence data.
Given the small sample size and potential for clustering
in one farm, this study should not be taken as a popula-
tion prevalence study, but rather as a comparison among
intestinal compartments and assessment of ribotype dis-
tribution. The detection of C. difficile in feces of healthy
horses shows that horses are exposed to this pathogen
frequently, however only a small subset of horses even-
tually develop disease. Better understanding of the epi-
demiology of this pathogen is required to better prevent
and treat disease.
Assessment of faecal samples is the standard practice
for diagnosis of disease caused by enteropathogens, be-
cause of the ease of access and the impractical nature of
sampling other intestinal compartments in most cases.
Therefore, understanding how faecal samples reflect
proximal compartments is critical for interpretation of
the data. Agreement between rectal samples and prox-
imal compartment was good (κ= 0.61), although these
data do indicate that rectal samples might not absolutely
reflect the status of proximal compartments, both in the
presence or absence of C. difficile and the ribotypes that
are recovered. These findings should be considered
when interpreting results from other studies, as preva-
lence of C. difficile in the gastrointestinal tract of horses
might be higher than faecal prevalence would suggest.
The presence of a variety of ribotypes in this study is
not surprising. Previous studies have reported a wide di-
versity of ribotypes in horses [24,27]. The most common
ribotype in this study was ribotype 078, commonly
found in pigs and cattle [28], and increasingly implicated
in community-associated CDI in humans [29,30]. While
ribotype 078 has been found in horses [9,23,28], the
prevalence here is higher compared to previous studies
of horses in this region, such as a 2006–2007 surveil-
lance study where ribotype 078 only accounted for 3/52
(5.8%) of isolates from healthy horses [9]. This could in-
dicate that this ribotype is emerging in this region. The
second most common strain in this study was ribotype
001. This ribotype has been previously reported in
horses [9,27] and is also a predominant human clone,
being the most common ribotype in a study of people in
hospitals in the region [31]. Overall, nine of the 14 (64%)
isolates found in this study were types that have been
implicated in CDI in humans in the region [31]. Data
such as these raise concern that C. difficile may be a
zoonotic pathogen [32]; however, proof of interspecies
transmission is currently lacking.
The low prevalence of C. perfringens in intestinal con-
tent samples obtained in this study is consistent with
previous studies. While C. perfringens is commonly
found in horses with enteric disease, foals and pregnant
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mares, the low prevalence reported here is consistent
with other studies of adult horses [13,16]. Methodo-
logical issues should always be considered with studies
reporting low prevalence. Standard and validated meth-
ods are not available for C. perfringens isolation from
equine faeces; however, the method used here had a de-
tection threshold of 9 cfu/ml of faeces (data not pre-
sented) and identical protocols were used in a study that
identified C. perfringens shedding in 88% of healthy dogs
[33]. Thus, it is unlikely that poor test sensitivity
accounted for the low prevalence reported here, and
these results suggest that C. perfringens is uncommonly
shed by healthy horses, or shed intermittently or at very
low levels. Whether the higher isolation rates from
horses with gastrointestinal tract disease indicates cause
or simply opportunistic overgrowth of this organism is
still unclear [13,15].
A limitation of this study was its small sample size and
therefore care has to be taken when interpreting these
results; however, this is the first study determining the
prevalence and ribotype distribution of C. difficile in dif-
ferent compartments of healthy horses and despite the
small sample size it gives new insight into the epidemi-
ology of this pathogen.
Information on antimicrobial use in the weeks prior to
euthanasia was not available; however, none of the
horses had any clinical condition reported that would
likely have been treated with parenteral antimicrobials.
It is certainly plausible that prior antimicrobial use
would have affected results of this study; however, any
effect would probably have been on overall prevalence,
not an alteration of distribution of C. difficile in different
intestinal locations. If there were any impact on C. per-
fringens, it would have been expected to increase the
prevalence, something that was not observed here given
the very low prevalence.
Conclusions
This study provides new epidemiologic data on the pres-
ence and distribution of C. difficile and C. perfringens
throughout the intestinal tract of healthy horses. While
faecal samples provide a reasonable indication of the pres-
ence or absence of these organisms in the proximal intes-
tinal tract, differences in C. difficile distribution and types
can be found in different intestinal locations, something
that must be considered when designing and interpreting
studies relying on faecal sample collection alone. While
the gastrointestinal microbiota of the horse remains a
poorly understood, complex and important polymicrobial
environment, a better understanding of important organ-
isms such as C. difficile and C. perfringens may help to elu-
cidate the epidemiology and microbiology of the intestinal
microbiota in health and disease.
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